TCL Archive Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable April 26, 2013
TCL Archive NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA. July 13, 2007
TCL Archive In Brief: Medical School Deans Biggest Enemy Of Cancer Program, Saunders Says; House Oks Line Item May 16, 1980